Navigation Links
Endovascular Forum and GEST Set Out on a Shared Venture to Bring the Highest Level of Embolization-based Scientific and Technical Education, Results, and Relevance for Patient Care
Date:11/11/2009

BOSTON, Nov. 11 /PRNewswire/ -- The Endovascular Forum (EVF), an IC Sciences company, announces today a new partnership with the Global Embolization Symposium and Technologies (GEST), and the launch of a dynamic online case-based interactive forum.

This endeavor is in line with the GEST mission and aim of bringing practitioners the highest level of scientific and technical education about the use of new materials and devices, their results, relevance for patient care, imaging, and to fine tune existing skills and expertise in these areas in the most innovative and dynamic method possible.

"This partnership between GEST, the world's leader in innovative and comprehensive forum for embolization science and education, and the Endovascular Forum, the premier innovative online community for endovascular physicians, is a beautiful match," said Dr. Ziv Haskal, one of the three co-founders of GEST. "We are very excited about linking our community with the far reach and vision of the EVF."

Embolization is one of the few areas in endovascular therapy that draws together all practitioners, regardless of their individual subspecialty practices. Obviously, for the interventional oncologist, embolization is the sine qua non. However, embolization spans peripheral vascular disease, trauma, visceral artery and venous interventions, pediatric and neurointerventional therapies, women's health, aortic disease, vascular malformations, gastrointestinal bleeding, liver disease, non-vascular procedures, cell-based therapies, etc.

In turn embolotherapy has become a central part of daily Interventional Radiology work. Embolization indications have substantially increased over the last decade and continue to do so. Fibroid embolization, trauma, and GI-hemorrhage are only a few areas manifesting this fast increase. Additionally, treatment of vascular malformations is fully dependent on embolization techniques. Oncology treatment with drug
'/>"/>

SOURCE IC Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
2. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
3. Abaxis, Inc. to Present at the Sidoti & Company Second Annual New York Institutional Investor Forum
4. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
5. Palatin Technologies to Present at 8th Annual BIO Investor Forum
6. Trubion Announces Upcoming Presentation at 8th Annual BIO Investor Forum
7. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual BIO Investor Forum
8. Novavax to Present at 8th Annual BIO Investor Forum 2009
9. Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009
10. VirtualScopics to Present at the 8th Annual Bio Investor Forum
11. Marc J. Fagel of the U.S. Securities and Exchange Commission to Discuss SEC Enforcement at CBIs Biotech/Pharma Finance and Accounting Forum in San Francisco
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... , Nov. 21, 2014 ... the European Medicines Agency (EMA) has granted ... company,s lead product candidate, for the treatment ... a rare, severely disabling genetic disease characterized ... swelling (flare-ups) and new abnormal bone formation. ...
(Date:11/21/2014)... 20, 2014  RedRick Technologies, a provider of ... room environment guidance, has helped the new Penn ... room, which may also serve as a model ... "In line with the tenets ... Radiology,s Imaging 3.0 ™ initiative, the new ...
(Date:11/21/2014)... CORAL GABLES, Fla. , Nov. 20, 2014 /PRNewswire/ ... working to become the first U.S. commercial producer of ... signed a contract with INVAP to design ... Alachua, Fla. Mo-99 is the parent isotope ... nuclear medicine procedures worldwide. In 2012, Congress passed legislation ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Coqui RadioPharmaceuticals Inks Deal With INVAP 2
... Trust, Inc. (NYSE: BMR ) announced ... with Omeros Corporation (NASDAQ: OMER ) ... Seattle, Washington.  A clinical-stage biopharmaceutical company committed to ... coagulopathies and disorders of the central nervous system, Omeros ...
... Feb. 1, 2012 Novartis announced today that following ... (FDA) has approved an update to the Gleevec ® ... of treatment after surgery for adult patients with KIT ... of recurrence inclusion criteria of the pivotal trial. This ...
Cached Medicine Technology:BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle 2BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle 3BioMed Realty and Omeros Sign New 64,500 Square Foot Lease in Seattle 4FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 2FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 3FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 4FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 5FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 6FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 7FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certain GIST patients after surgery 8
(Date:11/23/2014)... November 23, 2014 The report, ... 2006 to 2020 - Asia-Pacific” provides quantitative analysis ... market segments: minimally invasive body contouring devices, non-invasive ... analysis includes market size data by revenue and ... following countries: China, Japan, South Korea, Australia and ...
(Date:11/23/2014)... 2014 (HealthDay News) -- The holidays can be a ... overload can trigger major meltdowns, an expert says. ... of circumstances, but when you have children with special ... occupational therapy professor at University of the Sciences in ... best to let your hosts or visitors know what ...
(Date:11/23/2014)... 23, 2014 More than two dozen ... a federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), ... Liebhard LLP reports. , A Case List updated ... class of Type 2 diabetes medications referred to as ... District Court, Southern District of California, where a federal ...
(Date:11/23/2014)... November 23, 2014 Syngenta lawsuits are ... behalf of farmers and agribusinesses that have allegedly incurred ... commercialize Agrisure Viptera and Agrisure Duracade, genetically modified ... approved for sale in China. According to a report ... virtually ban U.S. corn imports. Because China is the ...
(Date:11/22/2014)... 2014 A new AlignLife Chiropractic & ... the downtown Greenville area. Dr. Chelsea Sineath, owner and ... to open her own clinic after working in another ... patients. , AlignLife believes that the body can ... focus on chiropractic care and rehabilitation to allow the ...
Breaking Medicine News(10 mins):Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 2Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 3Health News:Aesthetic Lasers and Energy Devices Market in APAC (China, Japan, South Korea, Australia and India) to 2020 4Health News:Holidays Can Be Sensory Overload for Kids With Autism 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2
... 28 (HealthDay News) -- While the hormone oxytocin makes people ... study shows. Oxytocin -- a naturally occurring hormone that ... an important role in social behavior. Increased levels of the ... overall caring, generosity and trust, but it hasn,t been known ...
... of the most spectacular migrations on Earth is that of ... Acknowledged as one of the wonders of the natural world, ... five-kilometre breeding migration. Now, scientists have discovered the key to ... a team led by the late Professor Steve Morris from ...
... Traumatic brain injury, currently considered a singular event ... is instead the beginning of an ongoing process that ... other diseases and disorders that can reduce life expectancy, ... Branch at Galveston. As such, traumatic brain injury ...
... study not only has confirmed that children who have ... more prone to emotional problems, but many of those ... or peer violence that could exacerbate those issues. ... on top of exposure to disaster had more anxiety, ...
... a small and cheap-to-build unmanned aerial vehicle (UAV) intended ... reduce risks to material and human lives. The seaplane ... plane to fly in severe weather conditions. The resulting ... payload of up to 40 kg. It is equipped ...
... single cochlear implant capable of giving sound in both ears ... of the South of England Cochlear Implant Centre (SOECIC), based ... is an electronic device that can help both adults and ... has two parts: an internal receiver/stimulator package and electrode array, ...
Cached Medicine News:Health News:Oxytocin Increases Trust, Not Gullibility 2Health News:Scientists discover key to Christmas Island's red crab migration 2Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 2Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 3Health News:Researchers urge reclassification of traumatic brain injury as chronic disease 4Health News:Victimized children involved with disasters more likely to have mental health issues 2Health News:Victimized children involved with disasters more likely to have mental health issues 3Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 2Health News:Shape-shifting robot plane offers safer alternative for maritime rescue 3Health News:Southampton to conduct UK's first cochlear implant operation to give sound in both ears 2
The Synoptiscope(L-2510B) has a wide variety of functions including binocular function diagnosis and treatment....
Inquire...
Security and confidence assured with porous tape; integral deodorizing/venting filter....
Inquire...
Medicine Products: